CW
UTHR icon

CreativeOne Wealth’s United Therapeutics UTHR Stock Holding History

CreativeOne Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Sell
2,408
-733
-23% -$365K 0.03% 453
2025
Q4 		$1.53M Buy
+3,141
New +$1.46M 0.04% 402
2025
Q2 		– Sell
-764
Closed -$236K – 1189
2025
Q1 		$236K Buy
764
+141
+23% +$48.3K 0.01% 950
2024
Q4 		$220K Buy
623
+23
+4% +$8.45K 0.01% 991
2024
Q3 		$215K Buy
+600
New +$203K 0.01% 882

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

CreativeOne Wealth's UTHR Position: Q1 2026 in Review

CreativeOne Wealth reduced its United Therapeutics (UTHR) stake by 23% in Q1 2026, selling an estimated $365K and leaving 2,408 shares worth $1.43M. The position accounts for 0.03% of the portfolio, ranked #453.

CreativeOne Wealth first reported a position in UTHR in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.53M in Q4 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • CreativeOne Wealth held 2,408 shares of United Therapeutics worth $1.43M as of Q1 2026.
  • CreativeOne Wealth sold 733 United Therapeutics shares in Q1 2026, an estimated $365K.
  • United Therapeutics made up 0.03% of CreativeOne Wealth's portfolio in Q1 2026, its #453 holding.
  • CreativeOne Wealth first reported a position in United Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • CreativeOne Wealth's United Therapeutics position peaked at $1.53M in Q4 2025.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.